Rome wasn’t built in a day… But there is another lesser-known type of keystone, one that plays an equally critical role in supporting the most revolutionary technology the world’s ever seen… artificial intelligence. And without it, the entire AI industry would collapse.

You must read this new presentation from Porter Stansberry.

Michael Weintraub net worth and biography

Michael Weintraub Biography and Net Worth

Director of Phreesia

Michael serves as Founding Chair of Phreesia. He is Co-Founder and Managing Partner of Ardan Equity, a healthcare enterprise software private equity firm. Previously, Michael was Co-Founder and Managing Partner of Optum Ventures. He was Co-Founder and CEO of Humedica, a pioneer and leader in the field of population health management and big data. Following Humedica’s acquisition by UnitedHealth Group (UHG), Michael broadened his role as President and CEO of Optum Analytics. Prior to launching Humedica, he was a Senior Managing Director at Leerink Partners (now SVB Leerink). Michael was CEO of PharMetrics, which was acquired by IMS Health (now IQVIA). He focuses on healthcare innovation as an Entrepreneur in Residence at Harvard Business School, an Advisory Board member of the Innovation and Digital Health Accelerator at Boston Children’s Hospital, and is on the board of The College Diabetes Network (CDN). Michael received a BA in Economics from Brandeis University and an MBA from Harvard Business School.

How do I contact Michael Weintraub?: The corporate mailing address for Mr. Weintraub and other Phreesia executives is 432 Park Avenue South 12th Floor, New York NY, 10016. Phreesia can also be reached via phone at (888) 654-7473 and via email at [email protected]. Learn More on Michael Weintraub's contact information.
Has Michael Weintraub been buying or selling shares of Phreesia?: Michael Weintraub has not been actively trading shares of Phreesia in the last ninety days. Most recently, Michael Weintraub sold 8,236 shares of the business's stock in a transaction on Thursday, August 5th. The shares were sold at an average price of $70.13, for a transaction totalling $577,590.68. Learn More on Michael Weintraub's trading history.
Who are Phreesia's active insiders?: Phreesia's insider roster includes Edward Cahill (Director), Allison Hoffman (General Counsel), Chaim Indig (CEO), David Linetsky (SVP), Gillian Munson (Director), Randy Rasmussen (CFO), Evan Roberts (COO), Amy Vanduyn (SVP), and Michael Weintraub (Director). Learn More on Phreesia's active insiders.
Are insiders buying or selling shares of Phreesia?: In the last twelve months, insiders at the sold shares 56 times. They sold a total of 151,985 shares worth more than $3,552,098.43. The most recent insider tranaction occured on October, 18th when SVP David Linetsky sold 1,100 shares worth more than $22,539.00. Insiders at Phreesia own 5.8% of the company. Learn More about insider trades at Phreesia.
Information on this page was last updated on 10/18/2024.

Michael Weintraub Insider Trading History at Phreesia

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction
8/5/2021	Sell	8,236	$70.13	$577,590.68
7/29/2021	Sell	1,754	$70.02	$122,815.08
7/21/2021	Sell	2,500	$65.15	$162,875.00
7/16/2021	Sell	20,000	$63.76	$1,275,200.00
1/19/2021	Sell	35,000	$63.86	$2,235,100.00
2/12/2020	Sell	10,680	$32.51	$347,206.80
2/10/2020	Sell	15,177	$32.79	$497,653.83

Michael Weintraub Buying and Selling Activity at Phreesia

Phreesia Company Overview

Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients. The company deploys its platform in a range of modalities, such as Phreesia Mobile, a patients' mobile device; Phreesia Dashboard, a web-based dashboard for healthcare services clients; PhreesiaPads, a self-service intake tablets; and Arrivals Kiosks, an on-site kiosks. It serves patients; single-specialty practices, multi-specialty groups, and health systems; and pharmaceutical, medical device, and biotechnology companies. The company was incorporated in 2005 and is based in Wilmington, Delaware.

Today's Range

Now: $18.64

$18.60

$18.72

50 Day Range

MA: $20.98

$18.04

$24.68

2 Week Range

Now: $18.64

$14.55

$29.16

Volume

5,904 shs

Average Volume

448,784 shs

Market Capitalization

$1.08 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.94

This company will win the AI race

From Porter & Company | Ad